Enterome nabs $52.6m

Enterome, a clinical-stage biopharmaceutical company, has raised $52.6 million in funding.

Enterome, a clinical-stage biopharmaceutical company, has raised $52.6 million in funding. The investors included SymBiosis, LLC, Takeda Pharmaceutical Company Limited, Seventure, Health for Life Capital, Principia, Omnes Capital and Nestlé Health Science.

Source: Press Release